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Abstract
Magnetic resonance imaging (MRI) is one of the non-invasive imaging modalities used in
longitudinal cell tracking. Previous studies suggest that MagA, a putative iron transport
protein from magnetotactic bacteria, is a useful gene-based magnetic resonance contrast
agent. Hemagglutinin (HA)-tagged MagA was stably expressed in undifferentiated
embryonic mouse teratocarcinoma, multipotent P19 stem cells to provide a suitable model
for tracking these cells during differentiation. Western blot and immunocytochemistry
confirmed the expression and membrane localization of MagA-HA in P19 cells. Elemental
iron analysis using inductively-coupled plasma mass spectrometry revealed significant iron
uptake in both parental and MagA-HA-expressing P19 cells, cultured in the presence of ironsupplemented medium. Withdrawal of this extracellular iron supplement revealed unexpected
iron export activity in P19 cells, which MagA-HA expression attenuated. The influence of
iron supplementation on parental and MagA-HA-expressing cells was not reflected by
longitudinal relaxation rates. Measurement of transverse relaxation rates (R2* and R2)
reflected changes in total cellular iron content. In particular, the reversible component R2′
(R2* ‒ R2) provided a moderately strong correlation to amount of cellular iron, normalized
to amount of protein.
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labelling, Cell contrast, Cell tracking

II

Acknowledgments
In completing my M.Sc. and throughout my educational career, there are numerous
people that deserve my grateful thanks. As such, I would like to briefly acknowledge them
for helping me to achieve this milestone.
I would first like to thank my supervisors Dr. Donna Goldhawk and Dr. Lisa
Hoffman. I have spent a considerable amount of time in your labs, as a graduate student
working towards my M.Sc. Dr. Goldhawk, thank you for always trying to help while things
went south. Thanks very much for all your patience and your time to help me. Dr. Hoffman,
thank you very much for listening to all my questions and doing your best to try to help me
make my research move forward. Thank you all for the trust to let me work in your lab to
explore new areas of research. Lastly, thanks for your continued support and guidance along
the way. Your continued passion and excitement for research is inspiring and has motivated
me a great deal in graduate school.
Next, I would like to thank my committee advisors Dr. Frank Prato, Dr. Terry
Thompson and Dr. Savita Dhanvantari for all the advice and guidance with my research and
help in my study. Dr. Thompson and Dr. Dhanvantari, thank you for not only providing
valuable advice, but also for taking your time to read my thesis. In addition, thank you all for
being on my qualifying exam committee.
I would also like to thank the many members of the Goldhawk and Hoffman Lab
(past and present) who have helped to create a great environment to conduct research. Thanks
for your advice on my research, and for advising me about various experiments. I particularly
would like to thank Becky McGirr who was always being so willing to help and share advice
based on her experiences in the lab. I truly appreciate it. Thanks also to Karina Quiaoit, Kelly
Gutpell, Anindita Sengupta, Casey Lee, Andrew Bondoc, Sarah Donnelly and many others in
the lab who have made research life enjoyable.
I’m especially grateful to my uncle, Junmin Liu. Thank you so much for all your
support. Thank you for picking me up at the airport when I first moved to Canada. Without
III

your kindly support, I couldn’t settle in Canada and be ready to put all my energy into my
study in such a short period of time. In addition, thank you so much for always trying to help
in any way you can. Your motivation, intelligence, and dedication really inspire me. Lastly,
thank you so much for your patience and for continually challenging me throughout my
education.
My final thanks are reserved for my parents for their unconditional love and support
throughout my life. Thank you for always being on my side to cheer me up. I’m so grateful
for the chance to study in Canada, which wouldn’t happen without your support. Mom, your
passion, integrity and work ethic have always had a great impact on me. Thank you so much
for all the advice, encouragement, selflessness, and kindness. Dad, thank you so much for
always comforting, challenging, and sharing your own life experience. Thanks so much for
believing in me and always being there to listen, support and encourage me. To both of my
parents, I could not have achieved this without you!

IV

Table of Contents
Abstract ............................................................................................................................... II	
  
Acknowledgments............................................................................................................. III	
  
List of Tables ................................................................................................................. VIII	
  
List of Figures .................................................................................................................. IX	
  
List of Abbreviations ......................................................................................................... X	
  
Chapter 1 ............................................................................................................................. 1	
  
1.1	
   Molecular and Cellular Imaging ............................................................................. 1	
  
1.1.1	
   MRI Relaxometry ....................................................................................... 3	
  
1.1.2	
   Contrast Agents for Cell Tracking with MRI Relaxometry........................ 5	
  
1.2	
   Role of MagA Expression in MRI .......................................................................... 6	
  
1.2.1	
   Magnetotactic Bacteria ............................................................................... 6	
  
1.2.2	
   MagA in Magnetotactic Bacteria ................................................................ 7	
  
1.2.3	
   Using MagA for MRI-based Cell Tracking ................................................ 7	
  
1.3	
   Overview of This Thesis ......................................................................................... 9	
  
1.3.1	
   Hypothesis................................................................................................... 9	
  
1.3.2	
   Motivation ................................................................................................... 9	
  
1.3.3	
   Choice of Cell Line ................................................................................... 10	
  
1.3.4	
   Thesis Objectives ...................................................................................... 10	
  
1.4	
   References ............................................................................................................. 11	
  
Chapter 2 ........................................................................................................................... 15	
  
2.1.	
   Introduction ........................................................................................................... 15	
  
2.2.	
   Methods................................................................................................................. 15	
  
2.2.1	
   Generation of a MagA-HA Expression Construct .................................... 15	
  
2.2.2	
   P19 Cell Culture, Transfection and Iron-loading ...................................... 16	
  
V

2.2.2.1	
   Cell of Choice ........................................................................................... 16	
  
2.2.2.2	
   Transfection Information .......................................................................... 16	
  
2.2.2.3	
   Iron Loading.............................................................................................. 17	
  
2.2.3	
   Protein Expression .................................................................................... 19	
  
2.2.3.1	
   Western Blot ............................................................................................. 19	
  
2.2.3.2	
   Immunocytochemistry (ICC) .................................................................... 19	
  
2.2.4	
   Trace Element (Iron) Analysis .................................................................. 20	
  
2.2.5	
   MRI of MagA-HA-expressing Cells......................................................... 21	
  
2.2.5.1	
   Phantom Preparation ................................................................................. 21	
  
2.2.5.2	
   Scanner and Pulse Sequences ................................................................... 21	
  
2.2.5.3	
   Region of Interest (ROI) ........................................................................... 22	
  
2.2.5.4	
   Calculation of R1, R2, R2* and R2'.......................................................... 23	
  
2.2.6	
   Data Analysis ............................................................................................ 24	
  
2.2.6.1	
   Sample Groups .......................................................................................... 24	
  
2.2.6.2	
   Statistical analysis ..................................................................................... 24	
  
2.3.	
   Results ................................................................................................................... 25	
  
2.3.1	
   Generation of a Stably-expressing Cell Line ............................................ 25	
  
2.3.2	
   Localization of MagA-HA in P19 Cells ................................................... 26	
  
2.3.3	
   Analysis of Cellular Iron in MagA-HA-expressing P19 Cells ................. 28	
  
2.3.4	
   MRI of MagA-HA-expressing Cells......................................................... 31	
  
2.4.	
   Discussion ............................................................................................................. 41	
  
2.5.	
   Conclusion ............................................................................................................ 45	
  
2.6.	
   References ............................................................................................................. 46	
  
Chapter 3 ........................................................................................................................... 49	
  
3.1	
   Summary ............................................................................................................... 49	
  
VI

3.2	
   Future Directions .................................................................................................. 49	
  
3.3	
   References ............................................................................................................. 51	
  
Appendix A: MagA-HA sequence ............................................................................... 52	
  
Appendix B: Raw data of relaxation rates for parental and MagA-HA expressing P19
cells in different media condition ......................................................................... 53	
  
Curriculum Vitae.......................................................................................................... 55	
  

VII

List of Tables
Table 1 Sequences of the primers used in the generation of a MagA-HA construct .............. 17

VIII

List of Figures
Figure 2.1 Diagram of the plasmid vector used for transfection ............................................ 18
Figure 2.2 Diagram of the MRI cell phantom used for the measurement of relaxation rates ....
................................................................................................................................................. 22
Figure 2.3 Localizer images of the spherical gelatin phantom ............................................... 23
Figure 2.4 Western blots of protein extracted from P19 cells ................................................ 26
Figure 2.5 MagA-HA co-localizes with WGA at the plasma membrane ............................... 27
Figure 2.6 MagA-HA co-localizes with p115 expression in the Golgi apparatus .................. 27
Figure 2.7 Elemental Analysis of Iron in Parental and MagA-HA-expressing P19 Cells ...... 29
Figure 2.8 Time Course of Iron Export in P19 Cells .............................................................. 30
Figure 2.9 Influence of iron supplementation on R1 in MagA-HA-expressing P19 cells ...... 32
Figure 2.10 Signal Decay Curves for Transverse Relaxation ................................................. 34
Figure 2.11 Influence of iron supplementation on R2* in MagA-HA-expressing P19 cells .. 36
Figure 2.12 Influence of iron supplementation on R2 in MagA-HA-expressing P19 cells .... 37
Figure 2.13 Influence of iron supplementation on R2ʹ in MagA-HA-expressing P19 cells ... 39
Figure 2.14 Comparison of R2ʹ′ and total cellular iron content .............................................. 40

IX

List of Abbreviations
αMEM

Alpha-minimum essential medium

AVG

Average

β –gal

β -galactosidase

B0

External magnetic field

BLI

Bioluminescence imaging

BSA

Bovine serum albumin

CT

X-ray computed tomography

ER

Endoplasmic reticulum

FID

Free induction decay

FBS

Fetal bovine serum

Fpn1

Ferroportin 1

Fe(II)

Ferrous iron

GFP

Green fluorescent protein

HA

Hemagglutinin

ICC

Immunocytochemistry

ICP-MS

Inductively-coupled plasma mass
spectrometry

Ig

Immunoglobulin

Kb

kilobase
X

NMR

Nuclear magnetic resonance

MAI

Magnetosome island

MS-1

M. magnetotacticum strain

M0

Net magnetization

MR

Magnetic resonance

MRI

Magnetic resonance imaging

MRS

Magnetic resonance spectroscopy

M.W.

Molecular weight

M

Net magnetization

Mz

Longitudinal magnetization

Mxy

Transverse magnetization

PBS

Phosphate-buffered saline

PET

Positron emission tomography

R2

Irreversible component of transverse relaxation
rate

R2*

Transverse relaxation rate

R2′

Reversible component of transverse relaxation
rate

ROI

Region of interest

SD

Standard deviation

SEM

Standard error of the mean
XI

SPECT

Single photon emission computed tomography

SPIO

Superparamagnetic iron oxide

T

Tesla

T1

Longitudinal relaxation time

T2

Irreversible component of total effective

transverse decay
T2*

Total effective transverse decay

T2′

Reversible component of total effective

transverse decay
TBS

Tris-buffered saline

TBS-T

Tris-buffered saline/0.1% tween 20

TE

Echo time

TR

Repetition time

TI

Inversion time

WGA

Wheat germ agglutinin

XII

Chapter 1
1.1 Molecular and Cellular Imaging
Broadly-speaking, molecular imaging is the in vivo evaluation of biological
processes at the cellular and molecular level [1]. By using molecular imaging techniques,
our ability to monitor cells and specific proteins within a living organism has been
tremendously improved [2]. For example, molecular imaging can be used to locate
specific groups of cells or the level of a given protein of interest in the cell, permitting
noninvasive characterization of the progression of disease(s) and development of
biomarkers of these processes [3]. In addition, the efficiency of treatment in small-animal
models of human disease can be assessed using molecular imaging [4]. Stem cell therapy,
for example, is a promising treatment for multiple diseases, such as neurodegenerative
disease and heart disease; however, in order to understand the fundamental behaviour of
stem cells, different molecular imaging modalities have been developed to better
understand stem cell survival, distribution and function in the targeted regions [5]. Many
traditional imaging modalities such as ultrasound, x-ray computed tomography (CT) and
magnetic resonance imaging (MRI) are based on nonspecific macroscopic changes that
distinguish pathological tissues from healthy ones but do not identify changes in gene
expression and other molecular interactions responsible for the disease [1]. To address
this shortcoming, molecular imaging attempts to exploit specific probes with intrinsic
contrast agent properties [2]. This transition from nonspecific to specific labeling
represents an outstanding improvement in targeting the disease process, providing new
opportunities for understanding integrative biology and for detecting and characterizing
disease at earlier stages.
Molecular imaging has been applied to long-term studies using different imaging
modalities such as optical imaging, CT, positron emission tomography (PET), single
photon emission computed tomography (SPECT), ultrasound and MRI. Each of the
imaging modalities has inherent advantages and limitations. Optical imaging is useful for
detecting the expression of fluorescent proteins, such as green fluorescent protein (GFP),
1

or the bioluminescent activity of luciferase (e.g. firefly luciferase), which is useful for
understanding aspects of intracellular activity. GFP, as an example, was identified in
1962; explored as a reporter gene in 1992 [6]; and then later examined for its ability to
maintain fluorescence in a variety of organisms [6, 7]. However, the use of GFP for
monitoring molecular changes in vivo is limited by the depth of light penetration and low
resolution (2-3 mm for optical fluorescence imaging and 3-5 mm for optical
bioluminescence) [2]. By comparison, PET and MRI have also been used to monitor gene
expression in living organisms, with the advantage of satisfactory depth of interrogation.
Nuclear medicine techniques use small amounts of radioactive material
(radiopharmaceuticals) to diagnose and treat diseases. PET has been used to evaluate the
metabolism of a particular organ or tissue by attaching different radioactive atoms, such
as 18F, 15O or 11C, to substances that are naturally consumed by the target organ or tissue.
Commonly used substances include 18F-fluorodeoxyglucose [1] and 11C-methionine [8].
By using the radiotracers, physiological and biochemical information can be obtained.
Although spatial resolution is relatively poor with nuclear medicine platforms (namely
PET and SPECT), co-registration with CT or MRI provides a hybrid imaging solution
(PET/CT, SPECT/CT, PET/MRI). The short half-life of medical radiotracers is essential
for the clinical utility of ionizing radiation but constrains direct radiolabelling of cells for
long periods of time (e.g. Indium-111 has a half-life of 2.8 days) and the number of
repeat imaging sessions.
MRI has a number of advantages over other imaging modalities: no ionizing
radiation is needed; tissue is imaged at high spatial resolution (25-100 µm in preclinical
settings, and approximately 1 mm in clinical settings); and depth of penetration is not a
concern [9]. Over the past two decades, MRI has been used in longitudinal studies [10,
11] for (repetitive) monitoring of stem cell engraftment, tumor growth and metastasis,
changes in pancreatic beta cell function during diabetes and cardiac cell activity after
heart attack [12]. Yet, despite all of its strengths, MRI fails to track cellular and
molecular activities with the sensitivity that has been achieved in optical imaging using
reporter genes such as the green fluorescent protein and luciferase [1] or in PET using
radiotracers. Here, the definition of sensitivity is the minimum concentration of imaging
2

agent that can be detected. The sensitivity of MRI is approximately 10-3-10-5 molar,
which is much lower than the sensitivity of PET (10-11-10-12 molar), optical fluorescence
imaging (10-9-10-12 molar) and optical bioluminescence imaging (10-15-10-17 molar). In
order to develop molecular MRI, cells must be labeled with a contrast agent to improve
cell tracking and the detection of molecular activity [13]. To understand how contrast
agents can improve MRI, information about how MRI works and why contrast agents
influence the MR signal will be explained below.

1.1.1

MRI Relaxometry
Relaxometry is the study or measurement of nuclear magnetic resonance (NMR)

relaxation parameters. NMR is a phenomenon that can be observed when a group of
nuclei containing an odd number of protons and/or neutrons is placed within a strong
magnetic field. When combined with spatial encoding methods, NMR leads to MRI: a
tool that can provide images of the macroscopic structure of biological systems.
Historically the word ‘nuclear’ was dropped from the nomenclature of this imaging
modality to avoid any misconceptions that there was ionizing radiation involved as in
Nuclear Medicine. Since more than 60 % of the human body is water (H20), hydrogen is
the most abundant element imaged in MRI. A hydrogen atom is composed of a nucleus
(with 1 proton and no neutrons) and a single orbital electron. The hydrogen ion (H+) is
often referred to as a ‘proton’ since that is the only particle left if the electron is removed.
Classically, protons are considered spinning charged particles with a small magnetic
moment typically denoted by the symbol µ. Without an external magnetic field, the
nuclear moments are in random directions and thus, the vector sum of the nuclear
magnetic moments (net magnetization, M) will be zero.
When nuclei with magnetic moments are placed in a strong external magnetic
field (B0), most magnetic moments will still have a random orientation [14] but there will
be a small net magnetic moment created (vector sum of all the magnetic moments)
aligned parallel (low energy state) to B0. Thus, M becomes non-zero and is along the
direction of the applied magnetic field [15].
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In addition, when protons are placed within B0, they experience a torque caused
by the interaction between the spins and the magnetic field, and start to precess at an
angular frequency defined as the Larmor frequency (ω0) and determined by the Larmor
equation:
ω0 = γ×B0

[1.1]

In Equation 1.1, γ is the gyromagnetic ratio, which is equal to 42.576 MhzT-1 for
hydrogen. Thus, the precession frequency is linearly related to the strength of the
magnetic field. For example, clinical MRI scanners are usually 1.5 Tesla (T) or 3 T and
provide a precession frequency for hydrogen of approximately 64 MHz and 128 MHz,
respectively.
In order to detect the MRI signal, an external oscillating magnetic field (B1) is
applied perpendicular to B0, i.e. in the x-y plane. The oscillation frequency of B1 is equal
to ω0. M will rotate (or precess) about B1 with a frequency (ω1) equal to γB1. Since B1 is
oscillating at the Larmor frequency, effectively it is rotating at the same frequency as the
‘spins’. The net magnetization rotates away from the Z-axis towards the X-Y plane. The
angle of rotation (α) of M is dependent on the duration and amplitude of B1. A 90-degree
pulse occurs when B1 is on long enough to cause a π/2 rotation of M. This transient B1
magnetic field is known as a radio frequency (RF) pulse since ω1 is in the MHz range.
Once the RF pulse is turned off, the magnetic moments will continue to precess at the
Larmor frequency and M will return exponentially to its original value parallel with B0,
which is defined as the equilibrium state. The process of returning to the equilibrium state
is referred to as ‘longitudinal’ relaxation. During relaxation, the nuclei lose energy by
exchange of energy with lattice around the nuclei. The time it takes M to return to 63% of
its original value following a 90-degree pulse is called T1. In NMR, this is often referred
to as the spin-lattice relaxation time as the spins give up the ‘extra’ energy they receive to
the surroundings or ‘lattice’. The lattice produces transient magnetic fields (usually due
to molecular motion) at the Larmor frequency [15].
Following the termination of the B1 RF pulse, the magnetization in the X-Y plane
(Mxy) will exponentially decay to 0 (excluding the T1 relaxation) and the characteristic
4

time (for Mxy to irreversibly decay to 37% of its original magnitude) for this decay is
called the transverse relaxation time (T2). This assumes that the only mechanism is
random fluctuations in the local magnetic field. In reality what is normally observed in
the free induction decay (FID) is the total effective transverse decay (T2*), which is a
combination of microscopic de-phasing (T2) and local magnetic field inhomogeneities
(T2′). T1, T2 and T2* are converted to decay rates (R1 = 1/T1, R2 =1/T2 and R2* =
1/T2*). The reversible component, R2′, is the difference between R2* and the irreversible
component, R2 (R2ʹ′ = R2* − R2). Related equations are thoroughly described in section
2.2.5.4.

1.1.2

Contrast Agents for Cell Tracking with MRI Relaxometry
Contrast agents can significantly improve the quality of a biomedical image and

enable targeted or functional imaging. MRI contrast agents are roughly categorized into
two groups: exogenous, such as gadolinium (Gd) [16], magnesium (Mg) [17] and superparamagnetic iron oxide (SPIO) particles [18] and endogenous agents, such as tyrosinase
[19], β-galactosidase (β-gal), ferritin and MagA. Most exogenous MRI contrast agents do
not directly contribute to the signal but alter the signal of the surrounding water protons
through their effects on relaxation rates.
Exogenous contrast agents can be roughly divided into two types: those that have
an influence on R1, such as gadolinium or manganese[20], and those that have an
influence on R2, such as superparamagnetic iron oxide (SPIO) particles [18]. Iron
introduces local magnetic field inhomogeneity (i.e., changes in R2ʹ′) and iron oxide-based
contrast has been increasingly used in MRI either as direct contrast agents in vivo, or as
indicators for monitoring specific proteins in vitro and in vivo. SPIO nanoparticles are
commonly used in the research setting and in clinical trials [13], often to label cells for
tracking with MRI [21]. Cells are usually labeled with SPIO ex vivo and imaged
following administration. Since the iron oxide nanoparticles are diluted by cell division,
SPIO-induced contrast may be lost over time.
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Compared to exogenous contrast agents, endogenous contrast agents can be
tracked over a long term without dilution caused by cell proliferation. Expression of MRI
reporter genes, which are under the control of a regulatory promoter, can be either easily
detectable or capable of storing certain elements that can improve the MRI contrast.
Genetically engineered cells expressing MRI reporter genes provide information on the
location, fluctuation and duration of transcriptional activity in living cells and animals.
Iron-related endogenous contrast agents are produced by the cell’s genetic machinery in
order to modulate the uptake, storage, and processing of iron [12]. Iron can act as a
paramagnetic metal depending on its oxidation and structure. In addition,
iron concentration will have an impact on MRI contrast. A few mammalian iron handling
proteins have been studies as potential MRI reporters [22]. For example, transferrin
receptor (TfR) and ferritin, present in mammalian cells, were investigated by researchers
for the capability of developing T2/T2* contrast on MR images [12, 23-25]. Genes from
magnetotactic bacteria will be discussed in Section 1.2.

1.2 Role of MagA Expression in MRI
1.2.1

Magnetotactic Bacteria
Magnetotactic bacteria are a group of prokaryotes that can synthesize magnetic

crystals called “magnetosomes” and typically arrange these in a chain within the cell.
These bacteria move along an external magnetic field through a process called
magnetotaxis. Blakemore et al. initially identified this unique phenomenon in the
microorganisms collected from the salt marshes of Cape Cod in 1975 and called them
magnetotactic bacteria after discovering the magnetosome structure within the bacteria
[26].
Magnetosome crystals are either composed of the magnetite (Fe3O4), or greigite
(Fe3S4), depending on the species. In comparison to mammalian ferritin, which is a

ferrihydrite core surrounded by protein, the relaxivity of magnetite or maghemite
particles in solution is approximately 700 times more than that of ferritin in solution or
tissue. There are approximately 28 genes involved [27] in the formation of
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magnetosomes. Although a full understanding of the process of magnetosome formation
is lacking, many applications of the unique magnetosome compartment have been
postulated [28], including its utility in cell tracking with MRI [12, 23, 24, 29].

1.2.2

MagA in Magnetotactic Bacteria
MagA was one of the genes originally thought to be involved in magnetosome

formation. Nakamura et al. reported that production of MagA may be involved in the iron
biomineralization process [30]. When MagA was expressed in E. coli, inverted
membrane vesicles within cells were shown to transport ferrous iron (Fe(II)) in an
energy-dependent manner, resulting in Fe(II) accumulation in the vesicle. These
observations suggested that MagA may function as an H+/Fe(II) antiporter in M.
magneticum sp. AMB-1 [31]. A full genomic analysis of AMB-1 confirmed that deletions
in MagA were present among a set of nonmagnetic mutants. Thus, MagA may play a role
in magnetosome formation, although further study is required to delineate its exact
function. More recently, a study from Uebe et al. showed that MagA is not an essential
magnetosome gene [32]. Nevertheless, MagA is a putative iron transport protein and a
candidate for MRI reporter gene expression [12, 23, 24, 29, 33].

1.2.3

Using MagA for MRI-based Cell Tracking
MagA and its potential utility in MR cell tracking have been reported and initial

results indicate that this technique is promising. The first report on MagA-expressing cell
tracking used human embryonic kidney (HEK) 293 FT cells to express MagA under the
control of an inducible promoter [29]. Zurkiya et al. introduced MagA from species MS-1
into a doxycycline-responsive gene construct, and generated a stably expressing cell line
in 293FT cells. MRI showed that MagA-derived contrast can be formed in vivo in
response to iron supplementation and can be used to track cells expressing MagA. They
compared the iron uptake in MagA-expressing cells in three different doxycycline
induction conditions (0, 0.5, 2 µg/ml) and found that with same amount of iron
supplementation (200 µM for four days), different amounts of doxycycline changed the
7

iron content of the cells. They also presented electron microscopic and X-ray powder
diffraction data as evidence of the ability of MagA-expressing 293FT cells to produce
magnetite nanoparticles. Goldhawk et al. expressed MagA from species AMB-1 in the
mouse neuroblastoma N2A cell line and used 11 T micro MRI and a novel dual echo
sequence (spin echo at an echo time (TE) of 5 ms and gradient echo at TE 15 ms) to
acquire three-dimensional MRI [33]. An important step in demonstrating the utility of
MagA-derived MR contrast for cell tracking is to show that MagA expression will lead to
changes in the relaxation rates, especially the transverse relaxation rates (R2*, R2 and
R2′). Expression of MagA in N2A cells generates intracellular contrast for MRI detection
at 11 T as measured by the decay rates [33].
Sengupta et al. compared the expression of MagA in MDA-MB-435 cells with the
overexpression of modified ferritin subunits, in which both heavy chain (HF) and light
chain (LF) lack iron response elements [23]. Their results showed that only transverse
relaxation rates were significantly higher in iron-supplemented, MagA- and HF+LFexpressing cells compared to non-supplemented cells and the parental control. R2*
provided the greatest absolute difference and R2′ showed the greatest relative difference,
consistent with the notion that R2′ may be a more specific indicator of iron-based contrast
than R2, as observed in brain tissue. Upon iron supplementation, the ratio of iron and zinc
increased about 20-fold in both MagA- and HF+LF-expressing cells, while the amount of
transferrin receptor expressed in these cells decreased more than 6-fold [23]. Thus,
despite a decrease in iron import, MagA activity resulted in an increase in cellular iron
content, comparable to unregulated ferritin storage. These results highlight the potential
of magnetotactic bacterial gene expression for improving MR contrast.
Understanding the MRI relaxation mechanism in these expression systems is
important for developing magnetosome-associated genes as cell tracking tools. To
optimize cell detection and specificity, develop quantification methods, and refine genebased iron contrast, a study by Lee et al. investigated the properties of mammalian cells
over-expressing MagA using 9.4 T NMR [34]. In this study, the relationship between R2
and interecho time was examined in both parental MDA-MB-435 and MagA-expressing
cells cultured in the presence and absence of iron supplementation. The relationship
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between R2 and interecho time was analyzed using the Carr-Purcell-Meiboom-Gill spin
echo sequence [35] and a model based on water diffusion in weak magnetic field
inhomogeneities [36] as well as a fast-exchange model [37]. Iron levels were assessed
with inductively coupled plasma mass spectrometry (ICP-MS). As expected from a
previous work [23], iron levels in iron-supplemented, MagA-expressing cells were higher
than in the other cell conditions. With regard to NMR, increases in R2 with increasing
interecho time were larger in iron-supplemented cells compared to unsupplemented cells
and the parental control. These findings provide insight into the high field relaxation
mechanisms in these MagA-expressing cells, which should be valuable for optimizing
MRI contrast for long-term cell tracking and monitoring of cellular activities.

1.3 Overview of This Thesis
1.3.1

Hypothesis
In this thesis, we hypothesized that MagA-induced iron accumulation can

generate detectable in vivo contrast, measurable by MRI relaxometry, in the P19 model of
stem cell behaviour.

1.3.2

Motivation
This thesis is motivated by the potential of stem cell therapy. Numerous animal

studies have shown success in delivering stem cells to treat a variety of diseases. Clinical
studies in stem cell therapy are promising. For example, recent studies show some
success in cell transplantation in the infarcted heart [38, 39].
MRI is widely used in cell tracking. Specifically, cells labeled with magnetically
visible contrast agents, which are either exogenous or endogenous, have great potential to
fulfill this goal. Using exogenous contrast agents, however, there is a limitation in
localizing those labeled cells over the long term once delivered to the organ. In order to
study or develop effective cell therapy, researchers have focused on genetically
9

modifying cells to take up iron. Compared to other techniques like labelling the cells with
exogenous contrast agents (SPIOs), MagA overexpression can provide stable labelling
for long-term in vitro and in vivo study.

1.3.3

Choice of Cell Line
The cell line used in all the experiments of this thesis is a mouse embryonic

teratocarcinoma denoted P19. These cells possess multipotent stem cell characteristics
and can differentiate into the three germ layers: endoderm, mesoderm, and ectoderm, as
specified by different chemical treatments [40, 41].
P19 cells grow rapidly without feeder cells and are effectively transfected with
DNA encoding recombinant genes. Addition of appropriate antibiotics to the cell culture
readily permits isolation of P19 cells stably expressing a gene of interest.

1.3.4

Thesis Objectives
The path for testing the hypothesis includes multiple sequential objectives. The

first objective (1) is to ensure that the MagA gene from magnetotactic bacteria can be
inserted into P19 cells and that MagA-transfected P19 cells are able to stably express
MagA. This was achieved with a hemagglutinin (HA)-tagged MagA expression construct.
To detect MagA protein, we performed Western blot analysis using a commercial HA
antibody as well as immunocytochemical localization.
The second objective (2) aims to demonstrate the level of iron uptake in
undifferentiated P19 cells and in the presence and absence of MagA-HA expression. Iron
supplementation was provided to both types of cells. To measure the total iron content in
parental and MagA-HA-expressing cells, ICP-MS analysis was used. We expected that
MagA-HA-expressing P19 cells would incorporate more iron than parental cells as
reported for other cell types [12, 23, 29, 33].
The third objective (3) is to determine whether undifferentiated, ironsupplemented parental and MagA-HA-expressing P19 cells can be distinguished using
MRI relaxometry. For both parental and MagA-HA-expressing P19 cells, transverse
10

relaxation rates (R2*, R2 and R2′) were measured and compared to total cellular iron
content.
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Chapter 2
2.1.

Introduction
Molecular Imaging has been used in the characterization and measurement of

biological processes [1] by exploiting molecular probes as contrast agents for imaging
modalities like CT, MRI and PET [2]. For longitudinal cell tracking by MRI, a few
techniques for tracking magnetically labeled cells have been proposed, including genebased approaches [3]. Previous studies suggest that MagA, a putative iron-transport
protein found in magnetotactic bacteria, can be used as an endogenous contrast agent for
MRI [4]. These reports indicate that MagA is involved in increasing cellular iron content,
as confirmed by MR relaxation rates and elemental analysis [5-7].
In the present study, we provide the first report of MagA expression in the P19
mouse teratocarcinoma cell line. We used an HA tag to verify MagA protein expression
and localization. We examined the response of parental and MagA-HA-expressing cells
to culture in the presence and absence of an extracellular iron supplement, measuring
total cellular iron content by ICP-MS. In addition, we adapted the methods previously
developed by Sengupta et al. to measure the relaxation rates of parental P19 cells and
those expressing MagA-HA using 3T MRI [6].

2.2. Methods
2.2.1

Generation of a MagA-HA Expression Construct
The tagged MagA-HA gene construct was kindly provided by Becky McGirr as a

cloned insert within pcDNA3.1 Zeo(+), under the control of the cytomegalovirus (CMV)
constitutive promoter (Life Technologies, Burlington, Canada). Using customized
primers to incorporate the HA sequence (underlined in reverse MagA_HA 5ʹ′ in Table 1)
and a published protocol (Goldhawk et al., 2009), MagA was cloned by polymerase chain
reaction (PCR) from Magnetospirillum magneticum sp. AMB-1 (ATCC, Burlington,
Canada). The resultant MagA-HA PCR fragment was sub-cloned into pCR2.1-TOPO
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(Life Technologies, Burlington, Canada) and shuttled into pcDNA 3.1 Zeo(+) at Kpn I/
Bam H1 (Figure 2.1).
The pcDNA3.1 Zeo(+)/MagA-HA construct expresses the HA epitope tag fused
to the C-terminus of MagA. The expression of MagA-HA was confirmed by Western blot
and immunocytochemistry (ICC), using commercially available antibodies (anti-HA
antibody, anti-p115 antibody). A stable MagA-HA-expressing cell line was obtained
using Zeocin antibiotic selection, as conferred by the BleoR resistance gene (Figure 2.1)
and detailed below.

2.2.2

P19 Cell Culture, Transfection and Iron-loading
2.2.2.1

Cell of Choice

Mouse multipotent teratocarcinoma cells (P19, ATCC) were transfected with
pcDNA3.1 Zeo(+)/MagA-HA and cultured under selection to obtain a clonal cell line
stably-expressing MagA-HA. Cells were cultured in alpha-minimum essential medium
(αMEM, Life Technologies, Burlington, Canada) and 10% fetal bovine serum (FBS) and
maintained under standard cell culture conditions (37oC, 5% CO2), passaging 1:10 when
the cells achieved 80-90% confluence. Whether replating or harvesting, cells were
routinely dissociated using 0.25% Trypsin/0.91 mM EDTA (Life Technologies,
Burlington, Canada).

2.2.2.2

Transfection Information

Transfection was performed using Lipofectamine 2000 (Life Technologies,
Burlington, Canada) according to the manufacturer’s instructions. Cells were 70-80%
confluent on the day before transfection and replated approximately 24 hours after
transfection at 1:20. Selection began 24 hours post-transfection using 200 µg Zeocin/ml
medium. After approximately two weeks under selection, distinct colonies of P19 cells
appeared on the plate. Several of these colonies were randomly selected and individually
replated in 6–well plates for further amplification on 100 mm2 dishes. At confluence,
these clonal lines were placed in cryostorage and used to examine the expression of
MagA-HA via Western blot, as described in the next section.
16

2.2.2.3

Iron Loading

To examine Mag-HA activity, cells were cultured in the presence or absence of
iron-supplemented medium, containing 250 µM ferric nitrate (Sigma-Aldrich, Oakville,
Canada). Following 7 days of iron supplementation, select plates were washed twice with
PBS (phosphate buffered saline, 137mM NaCl/ 2.7 mM KCl/ 10mM HPO42-) and
returned to non-supplemented medium for an additional 24 hours of culture. At harvest,
all plates of cells were washed twice with PBS and either prepared for MRI (described in
Section 2.2.5), or collected for protein analysis. The latter were collected in 1 to 2 ml of
ice-cold 50 mM Tris/5 mM EDTA pH 8/150 µL Complete Mini protease inhibitor cocktail
(Roche Diagnostic	
  Systems, Laval, Canada) and lysed by sonication.

Table 1 Sequences of the primers used in the generation of a MagA-HA construct
Sequence (5ʹ′-3ʹ′)

Primer Name
Forward

GGTACCGCCACCATGGAACTGCATCATCCCGAACTGACCTAT

MagA_5ʹ′

GCCGCCATCG

Reverse

CCGAGACCTTAACTTAAGATAGGCATACTACACGGCCTAAT

MagA-HA_3ʹ′

ACGCATTCCTAGGCGIX

17

Figure 2.1 Diagram of the plasmid vector used for transfection. The plasmid vector
map of pcDNA3.1 Zeo(+) was modified to indicate the site of insertion of the MagA-HA
DNA sequence, the relevant promoters, restriction enzyme sites used in cloning, and
available antibiotic resistance genes allowing selection of clones that stably express the
inserted DNA.

18

2.2.3

Protein Expression
2.2.3.1

Western Blot

Different clonal lines of MagA-HA-expressing P19 cells were cultured in 6-well
plates until the cells reached confluence. Clonal lines of MagA-HA-expressing P19 cells
(cell lines isolated as described above in Section 2.1.2) were prepared from cells cultured
in T75 flasks. At harvest, they were washed twice with PBS	
  and collected in 1 mL 50 mM

Tris/5 mM EDTA pH 8/150 µL Complete Mini protease inhibitor cocktail (Roche
Diagnostic Systems, Laval, Canada). Cells were lysed by sonication and protein

concentration was quantified using the BCA Protein Assay Kit [8] (Thermo Fisher
Scientific, Mississauga, Canada). Cellular proteins from each sample were separated by
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS PAGE, 40 µg/lane) on a
precast 4-12% gradient gel (Life Technologies, Burlington, Canada) and transferred to a
nitrocellulose membrane using the Original iBlot® Gel Transfer Device (Life
Technologies, Burlington, Canada). Blots were blocked with 5% blotto/Tris buffered
saline (TBS), 50 mM Tris-HCl pH 7.6/0.9% NaCl)/0.1% Tween 20 (TBS-T) for one
hour, followed by overnight incubation at 4oC with a monoclonal antibody against HA
(mouse anti-HA, 1:1,000 dilution, in 1% blotto/TBS-T). The following day, membranes
were washed four times in TBS-T and incubated with secondary antibody conjugated to
horseradish peroxidase (HRP) (HRP-goat anti-mouse Ig (Sigma-Aldrich, Oakville,
Canada), 1:5,000 dilution, in 1% Blotto/TBS for 1 hour. Immunoblots were subsequently
washed 3 times with TBS-T and once with TBS prior to development with a
chemiluminescent substrate (Super Signal, Thermo Scientific). Chemiluminescence was
captured using GeneSnap7.12 Software (Cambridge, England) while exposed in the
Chemigenius Gel Doc (Syngene) for 5 min.

2.2.3.2

Immunocytochemistry (ICC)

Sterile glass coverslips were placed in 6-well plates and rinsed with PBS prior to
seeding approximately 1 million MagA-HA-expressing P19 cells per well. At 70-80%
confluence, cells were washed with PBS, fixed with 2% paraformaldehyde (PFA)/PBS
for 30 min and permeabilized with 0.25% Triton X-100 (TX-100)/PBS for five min.
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After washing three more times with PBS, cells were incubated with blocking buffer
(10% goat serum/1% bovine serum albumin (BSA)/PBS) for one hour. Cells were
subsequently incubated overnight at 4oC with goat anti-HA (Abcam, 1:100 dilution in
10% goat serum/1% bovine serum albumin (BSA)/PBS). An antibody against mouse
Golgi-associated protein p115 (1:50, Transduction Laboratories, Lexington, KY) and
Alexa Fluor 594-conjugated wheat germ agglutinin (WGA, 5ug/ml in 10% goat
serum/1% bovine serum albumin (BSA)/PBS, Life Technologies, Burlington, Canada)
were also used to visualize the Golgi Apparatus and plasma membrane, respectively. The
secondary antibodies used were: Alexa Fluor 488-conjugated donkey anti-goat
immunoglobulin (Ig) and Alexa Fluor 594-conjugated donkey anti-mouse Ig (Life
Technologies, Burlington, Canada) respectively. After incubation with secondary
antibodies for two to four hours, cover slips were mounted on glass slides using ProLong
Gold Antifade Reagent (Life Technologies, Burlington, Canada). Cells were then
visualized with an Olympus IX81 wide field fluorescence microscope. Image acquisition
was carried out using In Vivo software. Ten optical sections per cell were collected in
0.2µm steps covering the z-axis field, using a 60 × oil immersion objective lens. Cell
images were processed using a three-dimensional (3D) blind deconvolution algorithm
provided in Image-Pro Plus software (Media Cybernetics, Inc., Rockville, MD, USA).

2.2.4

Trace Element (Iron) Analysis
Samples were sent to the Analytical Services Laboratory of Surface Science

Western at Western University (London, Canada) for trace element analysis of iron and
zinc using ICP-MS. To prepare samples, cells were cultured as described above and
harvested based on the confluency of T175 flasks, a day or two before or after the actual
day of MRI scanning. Cells were lysed in 1 mL 50 mM Tris-HCl pH 8/5 mM EDTA/150
µL Complete Mini protease inhibitor cocktail (Roche Diagnostic Systems, Laval, Canada)
and sonicated. The total protein from lysis of these cultured cells was quantified using the

bicinchoninic acid assay (BCA assay) [8]. Zinc provided a measure of cellular redox
status as well as a point of comparison to amount of iron. Iron content was then
normalized to quantity of total cellular protein as determined by the BCA assay. For each
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individual sample group, mean and standard error of the mean (SEM) were calculated in
Excel, version 14.3.8.

2.2.5

MRI of MagA-HA-expressing Cells
2.2.5.1

Phantom Preparation

Figure 2.2 depicts the spherical MRI cell phantom set-up for the measurement
of relaxation rates. Approximately 40-50 million cells were placed in each well. These
wells were custom-made from an NMR compatible material (Ultem, Lawson imaging
Prototype Lab). The dimensions of each well are: inner diameter 4 mm and height 10
mm. Samples were centrifuged at 400 × g and for 5 min to create a compact layer of cells
within each well. Cell pellets were overlaid with 1% gelatin (porcine type 1, SigmaAldrich, Oakville, Canada)/PBS and embedded in one hemisphere of a 9cm spherical
phantom filled with 4% gelatin/PBS. A spherical-shaped phantom was used to minimize
macroscopic magnetic field inhomogeneity which would interfere with accurate R2'
measurement. Samples consisted of either parental or MagA-expressing cells, cultured
under different conditions of iron supplementation: without extra iron supplementation,
with iron supplementation (250 µM ferric nitrate), and withdrawal of iron
supplementation after 7 days of continuous iron supplementation. To form the spherical
gelatin phantom, the empty hemisphere was filled with 4% gelatin/PBS and placed on top
of the half containing cell samples. Using a layer of parafilm, air was excluded in order to
avoid susceptibility artifacts at the interface [6].

2.2.5.2

Scanner and Pulse Sequences

The spherical phantom was placed in a 15-channel knee RF coil and scanned on a
3T mMR Biograph (Siemens AG, Erlangen, Germany) using previously described
sequences [6]. To acquire T1-weighed images, inversion recovery spin echo sequences
were used. Imaging parameters were as follows: echo time (TE) 13 ms; repetition time
(TR) 4000 ms; six inversion times (TI)= 22, 200, 500, 1000, 2000, 3900ms; flip angle=
90o; total scanning time approximately 39 min. To acquire T2-weighted images, a single
echo spin echo sequence and the following imaging parameters were employed: TE=13,
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30, 40, 60, 80, 100, 150, 200, 300 ms; TR=2010ms; flip angle= 90o; total scanning time
approximately 61 min. To acquire T2*-weighted images, a multi echo gradient echo
sequence was used with: TE=6.12, 14.64, 23.16, 31.68, 40.2, 50, 60, 70, 79.9 ms; TR=
200ms; flip angle= 60o; total scanning time approximately 25 min. For all MR images,
the field of view was 120×120 mm. For T1-weighted images, the volume of the voxels
was 1.5×0.9×0.9 mm3 and matrix size was 128×128. For T2- and T2*-weighted images,
the voxel size was 1.5×0.6×0.6 mm3 and matrix size was 192×192.

Figure 2.2 Diagram of the MRI cell phantom used for the measurement of
relaxation rates. Each hemisphere of a plastic 9-cm spherical mold was filled with 4 %
gelatin/PBS. Four different samples, prepared from parental and MagA-HA-expressing
cells cultured in the presence (+Fe) and absence of iron supplementation, were inlaid in
one of the hemispheres and arranged from left to right as follows: P19 (1), P19 + Fe (2),
MagA-HA (3), MagA-HA + Fe (4). A plastic marker was used to indicate orientation of
the samples.

2.2.5.3

Region of Interest (ROI)

The slice thickness was 1.5 mm and selected as shown in Figure 2.3. Slices were
oriented perpendicular to the sample wells to obtain a cross section through the cell layer
and avoid voxels from the bottom of the well and the top gelatin layer. Specifically, a
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ROI in each well was drawn using viewer code developed in Matlab 7.9.0 (R2010b),
including as many voxels as possible while excluding those closest to the wall of the well
(Figure 2.3 B). Overall, approximately 20 voxels were included in each ROI and average
signal intensity of the ROI for each time point and relaxation rate (R2, R2* and R1) were
determined with least-squares curve fitting (SigmaPlot 10.0.inc) of the mean ROI signal.
Note that manual selection of ROI was done by using a graphic user interface based on
Matlab 7.9.0 (R2010b) [6].

Figure 2.3 Localizer images of the spherical gelatin phantom. The images were
acquired by 3T MRI. A. In the sagittal view of the phantom, a yellow box indicates the
slice selected for image acquisition. B. A cross sectional view of the phantom shows the
alignment of sample wells. A plastic peg (black) provides orientation.

2.2.5.4

Calculation of R1, R2, R2* and R2'

R1 decay curves were obtained using an inversion recovery pulse sequence. R1
was determined with least-squares curve fitting of the mean ROI signals using Equation
2.1.
        S TI = 𝑆! · (1 − 2 · e!!"·!" +    𝑒 !!"·!" ) · 𝑒 !!"/!!                                                                                        2.1               
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R2* decay curves (average signal intensity over TEs) were obtained from the data
acquired using multi-echo spin echo sequences. R2 curves were obtained from single
echo spin echo pulse sequences. Sigmaplot 10.0 (Systat Software, Germany) was used to
fit R2 and R2* curves with a single exponential decay equation. A two-parameter model
was tested using the following equations.
S TE = S! e!!"·!"                                                                                          2.2a
    

∗

S TE = S! e!!"·!!                                                                                        2.2b               

Once R2* and R2 were determined, R2ʹ′ was calculated from the difference between R2*
and R2 (R2ʹ′=R2*-R2). For each individual sample group, mean and SEM of relaxation
rates (R1, R2*, R2 and R2′) were calculated in Excel.

2.2.6

Data Analysis
2.2.6.1

Sample Groups

To perform data analysis, samples were assigned to six groups: 1) parental P19
cells cultured in non-supplemented medium, P; 2) MagA-HA-expressing P19 cells
cultured in non-supplemented medium, M; 3) iron-supplemented parental cells, P+Fe; 4)
iron-supplemented, MagA-HA-expressing P19 cells, M+Fe; 5) P+Fe cells cultured for an
additional 24 hours in non-supplemented medium, P 24h- Fe; and 6) M+Fe cells cultured
for an additional 24 hours in non-supplemented medium, M 24h-Fe.

2.2.6.2

Statistical analysis

Two-way ANOVA was used to assess main effects and interaction between
variables. All tests were two-tailed and SPSS version 20.0 was the statistical package
used. Student’s t-tests were used to evaluate significant differences between parental and
MagA-HA-expressing P19 cells for each condition of iron supplementation. Linear
regression was tested with R2' as the dependent variable and iron concentration as the
independent variable. P<0.05 was set as the threshold of statistical significance.
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2.3. Results
2.3.1

Generation of a Stably-expressing Cell Line
Protein lysates of both untransfected parental P19 and MagA-HA-expressing cells

were collected and analyzed by Western blot. As shown in Figure 2.4A, protein lysates
from parental cells (lanes 1 and 2) showed no anti-HA immunostaining. In contrast,
varying degrees of HA-tagged protein are detected as a single band in transfected cells,
stably expressing MagA-HA (lanes 3-6 in Figure 2.4B). The predicted molecular weight
(M.W.) of MagA-HA is 46.8 KDa; the apparent M.W. of anti-HA bands is approximately
35 KDa, which is similar to results obtained in a recent report [9]. When the same blot
was reprobed with an anti-β-actin antibody, a single band was stained at a M.W. of
approximately 40 KDa, indicating relatively constant amounts of a common structural
protein in each lane (Figure 2.4 C and D). The reported size of β-actin is 42 KDa [10, 11].
Therefore, immunoblotting confirms the presence of HA-tagged protein (Figure 2.4B),
indicating the successful expression of MagA-HA in P19 cells. Comparison of panels B
and D indicates a highly expressing clone in lane 3, which was selected for use in all
subsequent experiments.
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Figure 2.4 Western blots of protein extracted from P19 cells. Lanes 1-2 contain
protein extracted from untransfected parental P19 cells; lanes 3-6 contain protein from
MagA-HA-expressing cells. Panels A and B were probed with antibody against HA to
detect MagA-HA expression. Panels C and D were probed with an antibody against betaactin, used as a loading control. Approximate M.W. is indicated in the left margin.

2.3.2

Localization of MagA-HA in P19 Cells
Using ICC and the antibody against HA, we examined the cellular localization of

MagA-HA in P19 cells. As shown in Figure 2.5A, MagA-HA is present at the plasma
membrane and within the intracellular compartment. Counterstaining with fluorescentlyconjugated wheat germ agglutinin provides confirmation of plasma membrane labelling
(Figure 2.5 B). Merging of panels A and B (Figure 2.5 C) reveals yellow fluorescence at
the plasma membrane, verifying the co-localization of MagA-HA and WGA at the
plasma membrane. To address the intracellular localization of MagA-HA (Figure 2.6),
cells were immuno-stained with an antibody specific to the cis-Golgi Apparatus (Figure
2.6 B). Merging of panels A and B (Figure 2.6 C) reveals intracellular yellow
fluorescence indicating co-localization of MagA-HA with the cis-Golgi Apparatus
membrane-associated protein p115.
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Figure 2.5 MagA-HA co-localizes with WGA at the plasma membrane. P19 cells
stably expressing MagA-HA were sequentially probed with (A) primary goat anti-HA
and secondary donkey anti-goat antibody conjugated to Alexa Fluor 488 (green
fluorescence) and (B) Alexa Fluor 594-conjugated WGA (red fluorescence). Merging
panels A and B provides yellow fluorescence (C) wherever MagA-HA and WGA colocalize in the plasma membrane. Scale bar = 15 µm.

Figure 2.6 MagA-HA co-localizes with p115 expression in the Golgi Apparatus.
P19 cells stably expressing MagA-HA were sequentially probed with (A) primary
goat anti-HA and secondary Alexa Fluor 488 conjugated donkey anti-goat Ig (green
fluorescence) and (B) primary mouse anti-p115 and secondary Alexa Fluor 594conjugated donkey anti-mouse Ig (red fluorescence). Merging panels A and B
provides yellow fluorescence (C) wherever MagA-HA and p115 are co-localized in
the Golgi Apparatus. Scale bar = 15 µm.
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2.3.3

Analysis of Cellular Iron in MagA-HA-expressing P19 Cells
The total cellular iron content of MagA-HA-expressing cells was examined using

ICP-MS and compared to the parental control. As shown in Figure 2.7, elemental iron in
both parental and MagA-HA-expressing cells is significantly increased after culture in
iron-supplemented medium containing 250 µM ferric nitrate (P vs. P+Fe, p<0.01; M vs.
M+Fe, p< 0.01). Under iron supplementation for 7 days, parental and MagA-HAexpressing P19 cells contain approximately 1580 ± 293 and 2100 ± 297 ng Fe/mg
protein, respectively; whereas, in unsupplemented culture, parental and MagA-HAexpressing P19 cells contain approximately 48.9 ± 4.7 and 60.9 ± 12.9 ng Fe/mg protein
respectively. It is noteworthy that MagA-HA expression does not cause any significant
change in cellular iron content in the absence of an extracellular iron supplement,
consistent with previous findings in MDA-MB-435 cells [6]. Surprisingly, however, after
7 days of iron supplementation total cellular iron content was not significantly different
(p > 0.05) between MagA-HA-expressing P19 cells and the parental control.
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Figure 2.7 Elemental Analysis of Iron in Parental and MagA-HA-expressing P19
Cells. Total cellular iron content was analyzed by ICP-MS and normalized to total
cellular protein. Cell samples were cultured at least 7 days in the presence (+Fe) and
absence (-Fe) of iron supplementation (250 µM ferric nitrate). Total cellular iron content
is significantly higher in both iron-supplemented cell types compared to the
unsupplemented samples. Error bars are ± SEM (*, p<0.05). P, parental controls; M,
MagA-HA-expressing cells; P-Fe: N=6; M-Fe: N=6; P+Fe: N=8; M+Fe: N=5.
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To further delineate the iron handling activities of P19 cells, their ability to retain
iron after the withdrawal of the extracellular supplement was examined (Figure 2.8).
Accordingly, after 7 days of iron supplementation, both parental and MagA-HAexpressing cells were returned to unsupplemented medium for an additional 24 hours of
culture. In Figure 2.8, a sharp decline in iron level was observed in the parental cell type
after one hour, which continued to diminish over 24 hours. However, the total cellular
iron content of MagA-HA-expressing cells decreased less than the parental control and
was maintained over 24 hours at a higher level than in parental P19 cells.

Figure 2.8 Time Course of Iron Export in P19 Cells. Both parental (P) and
MagA-HA-expressing (M) P19 cells were cultured in iron-supplemented medium
containing 250 µM ferric nitrate for 7 days followed by an additional 24 hours of
culture in non-supplemented medium. Samples were collected for analysis by ICPMS at 1, 2 and 24 hours after the removal of iron supplement and labeled as 1h-Fe,
2h-Fe and 24h-Fe respectively. Error bars are ± SEM (*, p< 0.05). P+Fe: N=8;
M+Fe: N=5; 1h-Fe (P, M): N=2; 2h-Fe (P, M): N=2, 24h-Fe (P, M): N=5.
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Together, Figures 2.7 and 2.8 show that untransfected and MagA-HA-expressing
P19 cells have a similar capacity to incorporate iron from an extracellular supplement but
different abilities to retain this iron. The parental P19 cell type demonstrates a substantial
iron export activity (+Fe vs. 24h-Fe, p < 0.01) as do the MagA-HA-expressing P19 cells
(+Fe vs. 24h-Fe, p<0.05). However, 24 hours after the withdrawal of iron supplement,
MagA-HA-expressing cells retain approximately 719 ± 52.6 ng Fe/mg protein, which is
significantly higher than the parental control (332 ± 53.6 ng Fe/mg protein, p < 0.01).

2.3.4

MRI of MagA-HA-expressing Cells
MR phantoms containing cell pellets from parental and MagA-HA-expressing

P19 samples were scanned at 3T. Figure 2.9 shows the mean values of the longitudinal
relaxation rates in parental and MagA-HA-expressing P19 cells cultured under three
different conditions: -Fe, no iron supplementation; +Fe, iron supplementation for at least
one week; 24h-Fe, at least a week of iron supplementation (+Fe) followed by an
additional 24 hours of culture in non-supplemented medium. No significant differences in
R1 measurements are observed between samples (p > 0.05).
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Figure 2.9 Influence of iron supplementation on R1 in MagA-HA-expressing P19
cells. Longitudinal relaxation rate was determined in parental cells (P, white bars) and
MagA-HA-expressing cells (M, black bars) cultured in the absence of iron
supplementation (-Fe), in medium containing 250 µM ferric nitrate for 7 days (+Fe) and
after withdrawal of iron from +Fe samples for 24h (24h-Fe). 3T MRI was performed as
previously described [6]. There is no significant difference between P and M within a
given culture condition (P-Fe vs. M-Fe and P+Fe vs. M+Fe). Error bars are ± SEM (*,
p<0.05). P-Fe: N=4; M-Fe: N=4; P+Fe: N=6; M+Fe: N=4; P 24h-Fe:N=2; M 24h-Fe:
N=3.
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When comparing the decay curves for R2 (Figure 2.10a) and R2* (Figure 2.10b)
within 80 ms, R2* shows a higher signal decay rate than R2. This is consistent with a
previous study in MDA-MB-435 [12]. R2* represents the total transverse relaxation rate
and includes both the reversible component R2' and the irreversible component R2. In
Figure 2.10, R2* decay shows a stronger difference between MagA-HA-expressing and
parental cells than R2 alone.
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Figure 2.10 Signal Decay Curves for Transverse Relaxation. A comparison between
(a) R2 and (b) R2* relaxation curves for parental and MagA-HA-expressing cell samples,
cultured in the presence and absence of iron supplementation. In order to compare the R2
and R2* curves, only time-points before 80ms are shown in the figure. The R2* curves
show a greater difference between the MagA-HA-expressing and parental cells than the
R2 decay curves.
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Previous studies show that total cellular iron content is significantly correlated to
R2' [49]. In the present study, transverse relaxation rates, R2, R2* and R2ʹ, all were
notably different in both parental and MagA-HA-expressing P19 cells. For each
relaxation rate, significant main effects for the iron condition were found using two-way
ANOVA (Figures 2.11-2.13, p<0.001). The bar charts in Figure 2.11 and 2.12 show the
mean values of the transverse relaxation rates of parental and MagA-HA-expressing P19
cells cultured under 3 different conditions: -Fe, +Fe and 24h-Fe. Significant differences
in R2* are observed in both parental and MagA-HA-expressing P19 cells for
continuously iron-supplemented and unsupplemented conditions (Figure 2.11, P-Fe vs.
P+Fe and M-Fe vs. M+Fe, p < 0.05). Similarly, significant differences in R2 are observed
in both cell types (Figure 2.12, P-Fe vs. P+Fe, p<0.01 and M-Fe vs. M+Fe, p < 0.05).
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Figure 2.11 Influence of iron supplementation on R2* in MagA-HA-expressing P19
cells. R2* was determined in parental cells (P, white bars) and MagA-HA-expressing
cells (M, black bars) cultured in the absence of iron supplementation (-Fe), in medium
containing 250 µM ferric nitrate for 7 days (+Fe) and after withdrawal of iron from +Fe
samples for 24h (24h-Fe). There is no significant difference between P and M within a
given culture condition (P-Fe vs. M-Fe and P+Fe vs. M+Fe). For different conditions of
iron supplementation, there is a significant difference in both P-Fe vs. P+Fe and M-Fe vs.
M+Fe. Error bars are ± SEM (*, p<0.05). P-Fe: N=7; M-Fe: N=4; P+Fe: N=8; M+Fe:
N=4; P 24h-Fe:N=2; M 24h-Fe: N=3.
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Figure 2.12 Influence of iron supplementation on R2 in MagA-HA-expressing P19
cells. R2 was determined in parental cells (P, white bars) and MagA-HA-expressing cells
(M, black bars) cultured in the absence of iron supplementation (-Fe), in medium
containing 250 µM ferric nitrate for 7 days (+Fe) and after withdrawal of iron from +Fe
samples for 24h (24h-Fe). There is no significant difference between P and M within a
given culture condition (P-Fe vs. M-Fe and P+Fe vs. M+Fe). For different conditions of
iron supplementation, there is a significant difference in both P-Fe vs. P+Fe and M-Fe vs.
M+Fe. Error bars are ± SEM (*, p<0.05). P-Fe: N=7; M-Fe: N=4; P+Fe: N=8; M+Fe:
N=4; P 24h-Fe:N=2; M 24h-Fe: N=3.
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In Figure 2.13, R2' measurements were comparable between parental and MagAHA-expressing P19 cells cultured in either the absence (-Fe) or presence (+Fe) of iron
supplementation (n = 4-7). Only MagA-HA–expressing P19 cells showed significantly
higher R2ʹ between two iron conditions (M-Fe vs. M+Fe, p< 0.05). After at least 1 week
of continuous iron supplementation, parental and MagA-HA-expressing P19 cells were
returned to culture for a further 24 hours in non-supplemented medium (24h-Fe). R2'
measurements in this sample set show that R2' for MagA-HA-expressing cells (n = 3) is
higher than parental cells (n = 2). These findings lend further support to the ICP-MS
results described above, even though more experiments should be done to reach statistical
significance.
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Figure 2.13 Influence of iron supplementation on R2ʹ in MagA-HA-expressing P19
cells. R2ʹ was determined in parental cells (P, white bars) and MagA-HA-expressing cells
(M, black bars) cultured in the absence of iron supplementation (-Fe), in medium
containing 250 µM ferric nitrate for 7 days (+Fe) and after withdrawal of iron from +Fe
samples for 24h (24h-Fe). There is no significant difference between P and M within a
given culture condition (P-Fe vs. M-Fe and P+Fe vs. M+Fe). For different conditions of
iron supplementation, there is a significant difference in both P-Fe vs. P+Fe and M-Fe vs.
M+Fe. Error bars are ± SEM (*, p<0.05). P-Fe: N=7; M-Fe: N=4; P+Fe: N=8; M+Fe:
N=4; P 24h-Fe:N=2; M 24h-Fe: N=3.
Figure 2.14 illustrates the correlation between the reversible transverse relaxation
rate R2ʹ and total cellular iron content. Data from both parental and MagA-HAexpressing P19 cells, cultured in the presence (+Fe and 24h-Fe) and absence (-Fe) of iron
supplementation, are graphed. In general, unsupplemented cultures exhibit low R2′, rising
with a moderately strong correlation to the increase in total cellular iron, normalized to
amount of protein. The Pearson’s correlation coefficient is approximately 0.6 (r2 = 0.34, n
= 13, p < 0.05).
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Figure 2.14 Comparison of R2ʹ′ and total cellular iron content. Samples include
parental cells (P, circles) and MagA-HA-expressing cells (M, squares) cultured in the
absence of iron supplementation medium (-Fe, n=2, open symbols), in medium
containing 250 µM ferric nitrate for 7 days (+Fe, n=2-3, black symbols) and after
withdrawal of iron for 24h (24h-Fe, n=2, dotted symbols). Relaxation rate measurements
were obtained from cell samples mounted in a gelatin phantom and scanned at 3T. The
plot shows a linear regression analysis of the relationship between R2′ and total cellular
iron content (p < 0.05).
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2.4. Discussion
In this study, we examined the expression and function of MagA-HA in
undifferentiated P19 cells to extend the development of gene-based iron labelling for
MRI to a model of stem cell biology. MR relaxation rates were investigated in the context
of total cellular iron content in both parental and MagA-HA-expressing cells cultured
under various conditions of iron supplementation (-Fe, +Fe and 24h-Fe). The results
reveal new features of P19 iron biochemistry and demonstrate the potential for MagA to
retain iron in P19 cells and alter MR contrast.
Protein analyses
A MagA expression construct incorporating an HA tag on the C-terminus expands
the study of MagA expression to include protein analyses using immune techniques and a
commercial antibody. A Western blot of MagA-HA-expressing P19 cells was used to
identify a highly expressing clonal cell line (Figure 2.4). The approximate M.W. of
MagA-HA is 35 KDa in agreement with a recent report using HA-tagged MagA to study
the MR signal in a mouse embryonic stem cell line [9]. Although the predicted M.W. of
MagA-HA is approximately 47 KDa, no post-translational processing of the N-terminal
has been reported to date.
While Western blotting confirmed the expression of MagA-HA in P19 cells, ICC
was conducted to examine the localization of MagA. In bacteria, MagA is a putative iron
transport protein localized in the membrane compartment [13]. In mammalian P19 cells,
HA-tagged protein was immuno-stained on the surface and within the intracellular
compartment of MagA-HA-expressing cells. Wheat germ agglutinin is an approximately
36 kDa carbohydrate-binding protein with an affinity for sialic acid and Nacetylglucosaminyl sugar residues, which are predominately expressed on the plasma
membrane of mammalian cells [14]. This lectin was used to examine the membrane
localization of MagA-HA. Immunocytochemical analysis showed that MagA-HA and
WGA co-localize at the plasma membrane of P19 cells (Figure 2.5). To investigate the
intracellular localization of MagA-HA, we used an antibody specific for p115, a Golgi
Apparatus associated protein. The Golgi Apparatus is an organelle in eukaryotic cells
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responsible for sorting protein and lipid, routing them to the appropriate cellular
compartment. Newly synthesized protein from the endoplasmic reticulum enters the
Golgi on the cis side and leaves on the trans side facing the plasma membrane [15]. In the
Golgi Apparatus, p115 is required for vesicle transport from the cis to the medial
compartments [16, 17]. Thus, the Golgi Apparatus functions as a molecular assembly line
in which membrane proteins may undergo extensive post-translational modification en
route to their final destination in the cell. This includes processing of proteins for
secretion or membrane localization [15]. Co-localization of MagA-HA and p115 in the
Golgi Apparatus implies that overexpressed protein is accumulating in the Golgi
vesicle(s) responsible for organizing membrane-associated protein within the cell (Figure
2.6). These results are consistent with published [7, 13] and unpublished data indicating
that MagA-HA is a membrane protein.
Iron analysis
Mammalian cells display elaborate regulation of iron uptake, storage, export and
distribution of intracellular iron [18]. It is a constituent of such important proteins as
hemoglobin, cytochromes, oxygenases, flavoproteins, and redoxins [19]. For iron uptake,
transferrin is an important extracellular antioxidant that binds iron tightly under
physiological conditions so that virtually no free iron is available for the production of
free radicals. The delivery of iron to cells involves receptor-mediated uptake of
transferrin-bound iron [20]. Moreover, by controlling the expression of the transferrin
receptor, through the interaction of iron binding proteins with iron response elements,
mammalian cells regulate the amount of iron they import from the extracellular
environment. This form of transferrin receptor-mediated iron uptake is present in most
cell types [21]. In contrast, Ferroportin 1 (Fpn1) is the only iron exporter identified to
date [18, 22-24] and its expression is largely restricted to enterocytes, macrophages and
hepatocytes [25]. Once Fe(II) is exported across the basal membrane of the cell by Fpn1,
the iron is oxidized by hephaestin, a multi-copper oxidase that interacts with plasma
transferrin [26, 27].
Thus, iron and its careful regulation are of crucial importance to living cells. In
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cultured P19 cells, the total cellular iron content increases dramatically in response to an
extracellular iron supplement (Figure 2.7). Continuous culture in the presence of ironsupplemented medium results in a significant 32-fold increase (p < 0.01) in total cellular
iron content. However, cellular iron content in parental cells also decreased abruptly with
time when iron supplementation was withdrawn (Figure 2.8). Within two hours, the total
cellular iron content decreased to 567 ± 181 ng iron/mg protein, approaching baseline
levels by 24 hours (Figure 2.8, p<0.05).
While MagA-HA-expressing P19 cells exhibited a similar uptake of iron as the
parental cell type after week long culture in iron-supplemented medium, the decrease in
total cellular iron content, when extracellular supplementation was withdrawn, was not as
great. In MagA-HA-expressing cells, total cellular iron content was more than 2-fold
greater that the parental control even after withdrawal of iron supplement for 24 h (Figure
2.8; p<0.01). The iron export function of P19 cells is unexpected and reveals previously
unrecognized iron handling abilities in this cell type. The preliminary data for parental
P19 cells (white bars for 1h-Fe and 2h-Fe in Figure 2.8) indicates high ferroportin
activity in addition to high transferrin receptor activity (Figure 2.7). This is similar to
what is reported for M2 macrophages [28]. The ability of MagA-HA expression to retain
iron in P19 cells indicates the potential of MagA activity to modulate intrinsic iron export
function.
MRI analysis
While the exact mechanism of MagA function in bacterial and mammalian cells
has not been fully characterized, the results in P19 agree with previous studies indicating
that MagA expression increases iron incorporation in mammalian cells. With
measurement of relaxation rates, we explored the potential for contrast enhancement in
P19 cells by the expression of MagA-HA. Longitudinal relaxation rates (Figure 2.9) were
influenced very little, by the striking increase in cellular iron and this is consistent with
other publications [6, 29]. On the other hand, the transverse relaxation rates (R2* and R2,
Figures 2.11 and 2.12, respectively) were strongly affected by iron supplementation in
both parental and MagA-HA-expressing P19 cells.
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Compared to unsupplemented cells, either parental or MagA-HA-expressing P19
cells, the transverse relaxation rates (R2* and R2) are significantly higher in ironsupplemented cells. However, there is no significant difference in these relaxation rates
between MagA-HA-expressing and parental P19 cells cultured continuously in the
presence of iron-supplemented medium. This is consistent with ICP-MS results, which
indicate that total cellular iron content in iron-supplemented MagA-HA-expressing cells
(M+Fe in Figure 2.13) is no different than the iron supplemented P19 control (P+Fe in
Figure 2.13). These data are not consistent with previous studies [4, 6, 7, 9]. In other cell
types, like MDA-MB-435, which downregulate transferrin receptor expression in
response to iron supplementation, there is little or no increase in cellular iron content or
relaxation rate in the absence of MagA expression [6]. Results in P19 suggest that the
parental cell type possesses high iron import activity, which masks the activity of MagA,
a putative iron transport protein from magnetotactic bacteria.
The detection of iron export activity in P19 cells prompted an investigation of
relaxation rates in samples collected 24 hours after the removal of iron supplement.
While there was little difference in R2 and R2* measurements at this time point, the iron
specificity of R2ʹ′ measurements indicated the potential for discerning smaller differences
in cellular iron content (Figure 2.13). R2′ was strongly affected by iron supplementation
in MagA-HA-expressing P19 cells (p < 0.05) and revealed little change in MR contrast
24 hours after the withdrawal of extracellular iron. Although the sample size needs to be
increased for statistical comparisons, it appears that R2′ may be a useful indicator of
cellular iron content in P19 and perhaps other iron exporting cells, like macrophages. In
MDA-MB-435 [6], the correlation between R2ʹ′ and total cellular iron content for MagAexpressing cells is robust (r = 0.96), with a low y-intercept indicating better iron-related
specificity than R2. In P19 cells, the correlation between R2ʹ′ and total cellular iron
content for parental and MagA-HA-expressing P19 cells is moderately strong (r = 0.6,
Figure 2.14). We speculate that the rapid rate of iron export, particularly in the parental
cell type, may be impacting this result. Using the MRI preparation protocol previously
published [6], it takes about 2-3 hours to prepare cell samples for the MRI experiment.
As shown in Figure 2.8, within two hours of the withdrawal of iron supplementation,
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cellular iron content of parental P19 drops to approximately one third of the value
measured in continuously supplemented (+Fe) controls. In this time frame, the amount of
iron also decreased in MagA-HA-expressing P19 cells, by approximately 2-fold. Once
more time points are examined to fully characterize the iron export activity in parental
and MagA-HA-expressing P19 cells, the rate of iron export may be used to calibrate the
flux in cellular iron content and its relationship to MRI measurements. Further
experiments are warranted.

2.5. Conclusion
Western blots and ICC demonstrated the expression and membrane localization of
MagA-HA in P19 cells. Extracellular iron supplementation of cultured cells significantly
increased the total iron content in both parental and MagA-HA-expressing P19 cells,
resulting in an increase in transverse relaxation rates. Withdrawal of iron supplementation
revealed substantial iron export activity in parental P19 cells. MagA-HA expression
attenuated this iron export function, permitting the cell to retain iron and MR contrast for
a longer period of time. This is the first report of the influence of MagA expression on an
iron exporting cell type.
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Chapter 3
3.1

Summary
This thesis describes the successful expression of MagA, a gene from the

magnetotactic bacterium species AMB-1, in undifferentiated P19 mouse embryonal
carcinoma cells and generation of a stable MagA-HA-expressing clonal cell line. Our
study reports the cellular location of MagA-HA using immunocytochemistry, the
response of MagA-HA-expressing cells to extracellular iron supplementation using mass
spectrometry and their magnetic properties using MR relaxation rates. A comparison to
parental P19 cells reveals (1) pronounced iron uptake and export functions not previously
described in this model of stem cell behaviour, (2) the influence of MagA on mammalian
iron export and (3) the ability of MagA-HA expression to provide MR contrast in an ironexporting cell type.

3.2

Future Directions
P19 cells are a mouse teratocarcinoma, multipotent stem cell line, which can be

chemically induced to differentiate into different cell lineages. Previous studies have
shown that P19 cells can be differentiated down the mesodermal lineage using dimethyl
sulfoxide (DMSO) [1]. Using this procedure, successfully differentiated P19 cells display
a beating cardiac muscle cell phenotype in culture, with appropriate
immunocytochemical staining of cardiac biomarkers [2]. In preliminary experiments,
differentiated MagA-HA-expressing P19 cells also exhibited a beating cardiac muscle
cell phenotype. However, further immunocytochemical experiments need to be done to
show that the expression of MagA-HA is fully compatible with cardiac differentiation.
Magnetosomes, the membrane bound crystals of magnetite or greigite, permit
magnetotactic bacteria to navigate along the geomagnetic field. In order to accumulate
the large quantities of iron needed for magnetosome production, pathways for active iron
uptake into the cell, and more specifically the magnetosomal compartment, are very
important. It is still not entirely clear which genes are involved in the process of
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magnetosome iron transport. Early genetic and biochemical studies indicated that MagA
might be involved in magnetosomal iron uptake. This led to development of MagA as a
genetic MRI reporter for non-invasive cell tracking in vivo. However, the gene for MagA
is not located within the magnetosome genomic island [3], which is assumed to contain
the essential genes necessary for the formation of magnetosomes in bacteria [4]. MmsF,
for example, is one of the genes encoded in the MAI region. Previous study indicates that
MmsF plays an important role in biomineralization of mature magnetite crystals, which
might make it suitable for study if MmsF-expressing P19 cells can increase cellular
relaxation rates.
During the time course of iron export in P19 cells (Figure 2.8), we saw a high iron
export activity in both parental and MagA-HA-expressing cells. More experiments
detailing the time course of iron export after withdrawal of iron supplementation are
needed in order to fully understand the influence of iron export. Zurkiya et al. showed
that iron uptake in 2B5 cells changes with time and doxycycline induction of MagA
expression [5]. An appreciation of the pattern of iron export in P19 cells may shed some
light on the variability between total cellular iron content and R2′. Preparation of the MR
phantom required large scale cell culture and in the time it took to harvest the samples
more iron may have been exported from the cells, potentially affecting the correlation of
cellular iron content and MR relaxation rates.
As shown in the appendix B, uncertainties in relaxation rate measurements are
well within an acceptable range, and do not explain the variability in MRI measurements.
However, as shown in Figure 2.8, iron content changes dramatically within hours of
withdrawal of iron supplementation, which suggests that iron content may vary during
the hours needed to prepare the MRI samples. As discussed above, iron homeostasis is a
tightly regulated process. The only recognized iron export protein in mammalian cells is
Fpn1, which is mainly found in enterocytes, macrophages and hepatocytes. Hepcidin is
an important regulator of iron homeostasis: degrading the iron exporter Fpn 1 and thus
influencing the exporting ability of cells. This has been substantiated by studies showing
that increased hepcidin concentrations in plasma can cause anemia. On the other hand,
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deficiency of hepcidin can cause iron overload [6]. In P19 cells, the addition of hepcidin
to culture medium prior to cell harvest might improve the relationship between total iron
content and R2′ by interrupting any residual iron export occurring during the hours of cell
phantom preparation.
In MDA-MB-435 cells [7], there is a strong correlation between the reversible
transverse relaxation rate, R2′ and total cellular iron content (r = 0.96). However, there is
not as strong a correlation between R2ʹ′ and total cellular iron content in P19 cells (Figure
2.14); the Pearson’s correlation coefficient, 0.6 (r2 = 0.34, n = 13), implies a moderate
correlation and suggests that while 34% of the variance in R2ʹ′ is explained by a change in
total cellular iron content, other factors are important. In addition to rate of iron export,
discussed above, further analysis, for example using an independent t test on both
parental and MagA-HA-expressing samples collected at 24h - Fe, will require additional
experiments.

3.3

References

1.

Jasmin, S., DC; Campos de Carvalho, AC; Mendez-Otero, R, Chemical induction
of cardiac differentiation in p19 embryonal carcinoma stem cells. Stem Cells
Dev, 2010. 19(3): p. 403-12.

2.

Douglas, G.M., R; Charlton, CL; Kagan, DB; Hoffman, LM; Luyt, LG;
Dhanvantari, S, Characterization of a far-red analog of ghrelin for imaging GHSR in P19-derived cardiomyocytes. Peptides, 2014. 54: p. 81-8.

3.

Uebe, R.H., V; Schüler, D, The MagA protein of Magnetospirilla is not involved
in bacterial magnetite biomineralization. J Bacteriol, 2012. 194(5): p. 1018-23.

4.

Nudelman, H.Z., R, Structure prediction of magnetosome-associated proteins.
Front Microbiol, 2014. 5(9): p. 1-17.

5.

Zurkiya, O.C., AW; Hu, X, MagA is sufficient for producing magnetic
nanoparticles in mammalian cells, making it an MRI reporter. Magn Reson Med.,
2008. 59(6): p. 1225-31.

6.

Ganz, T.N., E, Hepcidin and iron homeostasis. Biochim Biophys Acta, 2012.
1823(9): p. 1434-43.

7.

Sengupta, A., MRI relaxation rates: a quantative approach to track tumour cells
expressing MagA. Master Thesis, Western University, 2014.
51

Appendix A: MagA-HA sequence

Figure A. MagA-HA sequence in pcDNA3.1 Zeo(+)/MagA-HA. The sequence is
from the 5' insertion site to the stop codon following the HA tag. The numbers indicate
the location of the sequence in the plasmid. The HA tag is in bold, and MagA is
underlined. The start and stop codons are shaded. Unique restriction sites within this
region of the plasmid are identified.
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Appendix B: Raw data of relaxation rates for parental and
MagA-HA expressing P19 cells in different media condition
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Uncertainties correspond to each data point. ✖:, Uncertainty information was lost due to
computer malfunction. AVE: average; SD: standard deviation; SEM: standard error of the
mean.
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